We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Development, Reliability and Validity of the Telerehabilitation Satisfaction Questionnaire- TSQ

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT05520554
Recruitment Status : Active, not recruiting
First Posted : August 30, 2022
Last Update Posted : August 30, 2022
Information provided by (Responsible Party):
Sefa Eldemir, Gazi University

Brief Summary:
Parkinson's disease (PD), stroke, and Multiple Sclerosis (MS) are the most common neurological diseases. Today, physiotherapy and rehabilitation approaches together with optimal medical and surgical treatment form the basis of treatment for these diseases. Recently, it has been stated that various telerehabilitation interventions in the field of physiotherapy and rehabilitation may be an additional option to the rehabilitation approaches applied in the clinic. In addition, there are benefits such as continuity in patient education and rehabilitation, saving time and expenditure of individuals on the road. However, some problems arise in this form of treatment. Especially weak internet connection, sometimes requiring technical knowledge and expensive equipment can reduce the participation and satisfaction level of individuals. It is also important to evaluate the level of satisfaction in expanding the usability of telerehabilitation services and determining the best telerehabilitation service. For this reason, there is a need for questionnaires investigating the satisfaction level of physiotherapy and rehabilitation applied through telerehabilitation.

Condition or disease Intervention/treatment
Neurological Disease Other: Development of the Telerehabilitation Satisfaction Questionnaire

Detailed Description:

Questionnaire items were created in two stages. First, 5 experts will independently review the literature on "telerehabilitation" and "satisfaction". In addition, these experts will be asked to create a pool of questions based on their experiences in telerehabilitation and by taking the opinions of patients receiving telerehabilitation about satisfaction. Then, 5 experts will come together and obtain a single question pool containing the questions they deem important in their question pool. The second step will involve scaling the elements. In this study, scale items will be scored on a five-point Likert scale, ranging from 1, strongly disagree to 5, strongly agree.

Then, it will be applied to a pilot group of 10 people and it will be evaluated whether the items prepared by the experts are understood by the patients. In line with the expert opinion and the result of the pilot study, the final version of the scale will be decided and applied to MS, PD, and stroke patients who make up the study group. Finally, the validity and reliability of the questionnaire will be calculated.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 60 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Development, Reliability and Validity of the Telerehabilitation Satisfaction Questionnaire- TSQ in Neurological Diseases
Actual Study Start Date : August 15, 2022
Estimated Primary Completion Date : November 15, 2022
Estimated Study Completion Date : December 15, 2022

Resource links provided by the National Library of Medicine

Group/Cohort Intervention/treatment
Telerehabilitation Satisfaction
Telerehabilitation Satisfaction Group
Other: Development of the Telerehabilitation Satisfaction Questionnaire
This study will be examined the development, validity, and reliability of the Telerehabilitation Satisfaction Questionnaire in patients with MS.

Primary Outcome Measures :
  1. Telerehabilitation Satisfaction Questionnaire in patients with Neurological disease [ Time Frame: One week ]
    Patients get a minimum of 0 points (best condition) and a maximum of 4 points (worst condition) for each question on this scale.

  2. Beck Depression Inventory [ Time Frame: 1st day ]
    Back Depression Inventory. It is a 21-item list with each item consisting of a four-point ordinal scale ranging from 0 to 3, with 0 indicating the lowest level of depression and 4 the highest level of depression. (0 = best, 63 = worst)

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Neurological patients receiving physiotherapy and rehabilitation via telerehabilitation

Inclusion Criteria:

  • Voluntarily participate in research to accept
  • Mini-Mental Test score more than or equal 24
  • Previously receiving physical therapy through telerehabilitation

Exclusion Criteria:

  • Any visual, hearing, and perception problems that may affect the answering the questionnaire items.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05520554

Layout table for location information
Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation
Ankara, Turkey
Sponsors and Collaborators
Gazi University
Publications of Results:
Layout table for additonal information
Responsible Party: Sefa Eldemir, Principal Investigator, Gazi University
ClinicalTrials.gov Identifier: NCT05520554    
Other Study ID Numbers: 4- ND-Development-TSQ
First Posted: August 30, 2022    Key Record Dates
Last Update Posted: August 30, 2022
Last Verified: August 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Sefa Eldemir, Gazi University:
Multiple Sclerosis
Parkinson Disease
Additional relevant MeSH terms:
Layout table for MeSH terms
Nervous System Diseases